BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Huguet JM, Lobo M, Labrador JM, Boix C, Albert C, Ferrer-Barceló L, Durá AB, Suárez P, Iranzo I, Gil-Raga M, Burgos CB, Sempere J. Diagnostic-therapeutic management of bile duct cancer. World J Clin Cases 2019; 7(14): 1732-1752 [PMID: 31417920 DOI: 10.12998/wjcc.v7.i14.1732]
URL: https://www.wjgnet.com/1948-5182/full/v7/i14/1732.htm
Number Citing Articles
1
Alireza Nemati, Mohamad Sadegh Aghajanzadeh, Mahdi Rooberahan. An Overview on Cancer Diagnosis based on Antibody-Based Immune TechniquesModern Medical Laboratory Journal 2020; 3(2): 100 doi: 10.30699/mmlj17.3.1.100
2
Dina Ioffe, Pooja Phull, Efrat Dotan. Optimal Management of Patients with Advanced or Metastatic Cholangiocarcinoma: An Evidence-Based ReviewCancer Management and Research 2021; : 8085 doi: 10.2147/CMAR.S276104
3
Elmira Zolali, Sina Rashedi, Elaheh Dalir Abdolahinia, Nasim Rashedi, Saeideh Allahyari, Nastaran Hashemzadeh. Principles of Biomaterials Encapsulation : Volume Two2023; : 589 doi: 10.1016/B978-0-12-824345-9.00019-2
4
Cosmas Rinaldi Adithya Lesmana, Baiq Kirana D. Mandasari. Immunosuppression2020;  doi: 10.5772/intechopen.94754
5
Purva Gopal, Marie E. Robert, Xuchen Zhang. Cholangiocarcinoma: Pathologic and Molecular Classification in the Era of Precision MedicineArchives of Pathology & Laboratory Medicine 2024; 148(3): 359 doi: 10.5858/arpa.2022-0537-RA
6
Nhu-An Pham, Nikolina Radulovich, Emin Ibrahimov, Sebastiao N. Martins-Filho, Quan Li, Melania Pintilie, Jessica Weiss, Vibha Raghavan, Michael Cabanero, Robert E. Denroche, Julie M. Wilson, Cristiane Metran-Nascente, Ayelet Borgida, Shawn Hutchinson, Anna Dodd, Michael Begora, Dianne Chadwick, Stefano Serra, Jennifer J. Knox, Steven Gallinger, David W. Hedley, Lakshmi Muthuswamy, Ming-Sound Tsao. Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancersScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-90049-1
7
Milind Javle, Sunyoung Lee, Nilofer S Azad, Mitesh J Borad, Robin Kate Kelley, Smitha Sivaraman, Anna Teschemaker, Ishveen Chopra, Nora Janjan, Shreekant Parasuraman, Tanios S Bekaii-Saab. Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017The Oncologist 2022; 27(10): 874 doi: 10.1093/oncolo/oyac150
8
Josep Darbà, Alicia Marsà. Analysis of hospital incidence and direct medical costs of intrahepatic cholangiocarcinoma in Spain (2000-2018)Expert Review of Pharmacoeconomics & Outcomes Research 2021; 21(3): 425 doi: 10.1080/14737167.2021.1842201
9
Yawei Qian, Wenyu Jia, Hongda Liu. Editorial: Biomarkers and immunotherapy of hepatic-biliary-pancreatic cancersFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1301416
10
Ruochen Ying, Anmol Mittal, Kaveh Hajifathalian. Rare Manifestation of Pancreaticobiliary Cancer With Extrahepatic LesionsCureus 2023;  doi: 10.7759/cureus.43276
11
Ji Hye Jung, So Jeong Yoon, Ok Joo Lee, Sang Hyun Shin, In Woong Han, Jin Seok Heo. Surgical outcomes and prognostic factors of distal common bile duct adenocarcinoma: chronological analysis in a single high-volume institutional experienceBMC Surgery 2022; 22(1) doi: 10.1186/s12893-022-01649-1
12
Filippo de Braud, Juan Valle, Angela Lamarca, David Malka, Antoine Hollebecque. Targeting Fibroblast Growth Factor Receptor Alterations in Cholangiocarcinoma and Other Solid Tumours: A New Frontier in Personalised MedicineEMJ Oncology 2022; : 2 doi: 10.33590/emjoncol/10184268
13
Gülşah BAYRAM ILIKAN, İlkay AKMANGİT. Percutaneous Transhepatic Cholangiography, Percutaneous Biliary Drainage and Metallic Endoprotesis Applications in Malign Biliary ObstructionsJournal of Contemporary Medicine 2021; 11(1): 97 doi: 10.16899/jcm.764141
14
Jieling Zheng, Shaobo Yao. [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancerEuropean Journal of Nuclear Medicine and Molecular Imaging 2020; 47(9): 2078 doi: 10.1007/s00259-020-04847-2
15
Tanios S Bekaii-Saab, Juan W Valle, Eric Van Cutsem, Lorenza Rimassa, Junji Furuse, Tatsuya Ioka, Davide Melisi, Teresa Macarulla, John Bridgewater, Harpreet Wasan, Mitesh J Borad, Ghassan K Abou-Alfa, Ping Jiang, Christine F Lihou, Huiling Zhen, Ekaterine Asatiani, Luis Féliz, Arndt Vogel. FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma withFGFR2rearrangementsFuture Oncology 2020; 16(30): 2385 doi: 10.2217/fon-2020-0429
16
Ghassan K. Abou-Alfa, Kristen Bibeau, Nikolaus Schultz, Amin Yaqubie, Brittanie Millang, Haobo Ren, Luis Féliz. Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic CholangiocarcinomaTargeted Oncology 2022; 17(5): 517 doi: 10.1007/s11523-022-00906-w